ORIGINAL RESEARCH article
Front. Mol. Neurosci., 14 September 2017
Sec. Molecular Signalling and Pathways
Volume 10 - 2017 | https://doi.org/10.3389/fnmol.2017.00293
RETRACTED: Rosiglitazone Exerts an Anti-depressive Effect in Unpredictable Chronic Mild-Stress-Induced Depressive Mice by Maintaining Essential Neuron Autophagy and Inhibiting Excessive Astrocytic Apoptosis
- ZZ
Zhan Zhao 1
- LZ
Ling Zhang 1
- XG
Xu-Dong Guo 1
- LC
Lu-Lu Cao 1
- TX
Teng-Fei Xue 1
- XZ
Xiao-Jie Zhao 2
- DY
Dan-Dan Yang 1
- JY
Jin Yang 1
- JJ
Juan Ji 1
- JH
Ji-Ye Huang 1
- XS
Xiu-Lan Sun 1*
1. Neuroprotective Drug Discovery Key Laboratory, Department of Pharmacology, Nanjing Medical University Nanjing, China
2. Neuroprotective Drug Discovery Key Laboratory, Department of Forensic Medicine, Nanjing Medical University Nanjing, China
Summary
Citation
Zhao Z, Zhang L, Guo X-D, Cao L-L, Xue T-F, Zhao X-J, Yang D-D, Yang J, Ji J, Huang J-Y and Sun X-L (2017) RETRACTED: Rosiglitazone Exerts an Anti-depressive Effect in Unpredictable Chronic Mild-Stress-Induced Depressive Mice by Maintaining Essential Neuron Autophagy and Inhibiting Excessive Astrocytic Apoptosis. Front. Mol. Neurosci. 10:293. doi: 10.3389/fnmol.2017.00293
Received
23 June 2017
Accepted
31 August 2017
Published
14 September 2017
Volume
10 - 2017
Edited by
Ildikó Rácz, University Hospital Bonn, Germany
Reviewed by
Wei Chen, Beijing Institute of Pharmacology and Toxicology, China; Xiaolu Zhang, Northern Jiangsu People’s Hospital, China
Updates
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.